FDA panel votes against new Avastin use

| By HealthLeaders Media Staff
| December 07, 2007

Advisors for the Food and Drug Administration say that Genentech's Avastin cancer drug should not be approved for expanded use in breast-cancer patients.

Full story

Tagged Under:

Most Popular

#1

The Ending of the Physician Era. Begin the Age of the APP.

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

AI Won't Save Healthcare. But It Will Help. If We Let It.

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...

Search form

FDA panel votes against new Avastin use

Share this:

Tagged Under:

Most Popular

The Ending of the Physician Era. Begin the Age of the APP.

AI Won't Save Healthcare. But It Will Help. If We Let It.

Get the latest on healthcare leadership in your inbox.